A microassay for measurement of Fc function of human immunoglobulin preparations by using tetanus toxoid as antigen

Biologicals

Volumn 32, Issue 2, 2004, Pages 78-83

  Vrdoljak, Anto ^a   Trescec, Anda ^a   Benko, Bojan ^a   Simic, Mirjana ^a  

^a INSTITUTE OF IMMUNOLOGY   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; TETANUS ANTIBODY; TETANUS TOXOID; VIRUS ANTIGEN;

ACCURACY; ARTICLE; CONTROLLED STUDY; HUMAN; MICROTITER PLATE ASSAY; PRIORITY JOURNAL; PROTEIN FUNCTION; RUBELLA VIRUS; VIRUS INACTIVATION;

ANTIBODY FORMATION; ANTIGENS, VIRAL; BUFFERS; CHEMISTRY; ERYTHROCYTES; HEMOLYSIS; HUMANS; HYDROGEN-ION CONCENTRATION; IMMUNOGLOBULINS; IMMUNOGLOBULINS, INTRAVENOUS; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; RUBELLA; RUBELLA VIRUS; TETANUS TOXOID; TIME FACTORS;

EID: 5344225293     PISSN: 10451056     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biologicals.2004.03.001     Document Type: Article

References (20)

1. Morell A. The perfect immunoglobulin replacement therapy. Waters A.H., Webster A.D.B. Intravenous immunoglobulins. 1985;47-59 Royal Society of Medicine, London
2. Curling J.M. Methods of plasma protein fractionation. 1980;Academic Press, London
3. Curling J.M. Separation of plasma proteins. 1983;Pharmacia Fine Chemicals AB, Uppsala
4. Moli S.L., Nisini R., Fattorossi A., Matricardi P.M., D'Amelio R. Intravenous immunoglobulin preparations. A comparative in vitro study of Fc mediated functions. J Clin Lab Immunol. 29:1989;79-84
5. Tono-Oka T., Matsumoto T., Imai K., Matsumoto S. Effect of gammaglobulin preparations on phagocytic function of whole blood. Biomed Pharmacother. 39:1985;477-481
6. Givner L.B., Edwards M.S., Anderson D.C., Baker C.J. Immune globulin for intravenous use: enhancement of in vitro opsonophagocytic activity of neonatal serum. J Infect Dis. 151:1985;217-220
7. Law D.T.S., Painter R.H. An examination of the structural and biological properties of three intravenous immunoglobulin preparations. Mol Immunol. 23:1986;331-338
8. Ph Eur. 2002:2.7.9.
9. Gronski P., Kanzy E.J., Seiler F.R. Measurement of Fc function on human immunoglobulin preparations. Pharmeuropa. 3:1991;287-292
10. Kotitschke R. Assessment of the Fc function in human immunoglobulins for intravenous administration. Infusionsther Transfusionsmed. 20:1993;93-95
11. Ramasamy I., Tran E., Charnock A., Farrugia A. Flow-cytometric method for the quantitation of the Fc function of intravenous immunoglobulin preparations. Vox Sang. 78:2000;185-193
12. Yang Y.H., Ngo C., Yeh I.N., Uemura Y. Antibody Fc functional activity of intravenous immunoglobulin preparations treated with solvent-detergent for virus inactivation. Vox Sang. 67:(4):1994;337-344
13. Bird P., Lowe J., Stokes R.P., Bird A.G., Ling N.R., Jefferis R. The separation of human serum IgG into subclass fractions by immunoaffinity chromatography and assessment of specific antibody activity. J Immunol Methods. 71:1984;97-105
14. Seppälä I.J.T., Routonen N., Sarnesto A., Mattila P.A., Mäkelä O. The percentages of six immunoglobulin isotypes in human antibodies to tetanus toxoid: standardization of isotype-specific second antibodies in solid-phase assay. Eur J Immunol. 14:1984;868-875
15. Aboud S., Matre R., Lyamuya E.F., Kristoffersen E.K. Antibodies to tetanus toxoid in women of childbearing age in Dar es Salaam and Bagamoyo, Tanzania. Trop Med Int Health. 6:(2):2001;119-125
16. Semba R.D., Muhilal D.P., Scott A.L., Natadisastra G., West K.P. Jr., Sommer A. Effect of vitamin A supplementation on immunoglobulin G subclass responses to tetanus toxoid in children. Clin Diagn Lab Immunol. 1:(2):1994;172-175
17. Lagergard T., Thiringer K., Wassen L., Schneerson R., Trollfors B. Isotype composition of antibodies to streptococcus group B type III polysaccharide and to tetanus toxoid in maternal, cord blood sera and in breast milk. Eur J Pediatr. 151:(2):1992;98-102
18. Swartz T.A., Saliou P., Catznelson E., Blondeau C., Gil I., Peled T., et al. Immune response to a diphtheria and tetanus toxoid administration in a three-dose diphtheria tetanus whole-cell pertussis/enhanced inactivated poliovirus vaccination schedule: a 7-year follow up. Eur J Epidemiol. 18:(8):2003;827-833
19. Aboud S., Lyamuya E.F., Kristoffersen E.K., Matre R. Immunity to tetanus in male adults in Dar es Salaam, Tanzania. East Afr Med J. 79:(2):2002;73-76
20. Kruger S., Muller-Steinhardt M., Kirchner H., Kreft B. A 5-year follow-up on antibody response after diphtheria and tetanus vaccination in hemodialysis patients. Am J Kidney Dis. 38:(6):2001;1264-1270